What Is the Wolverine Blend? BPC-157 + TB-500 Explained

• BPC-157 – blood vessels and growth factors: in animal studies it promotes new blood vessel formation (angiogenesis), increases growth hormone receptors in tendon cells and interacts with the nitric oxide system.
• TB-500 – cell movement: it binds actin, a building block of the cell skeleton, helping cells such as fibroblasts and blood-vessel cells migrate into injured tissue.
• Inflammation: both have shown anti-inflammatory effects in animal models.

BPC-157. Dozens of rat studies, most from one group at the University of Zagreb, report faster healing of tendons, ligaments, muscle, bone and the gut lining. Human data are limited to a few small pilot studies and case reports.

TB-500 and thymosin beta-4. Full-length thymosin beta-4 has been tested in human trials for eye injuries, skin wounds and heart attacks, with mixed results. TB-500 is a shorter fragment, and findings for the full protein may not apply to it.

The combination. There are no published studies of BPC-157 and TB-500 given together. Claims that the blend is synergistic are based on theory and anecdotes.

There is no human safety data for the combination and very little for either peptide alone. Because both promote blood vessel growth and cell migration, researchers have raised theoretical concerns about use in people with cancer, where those processes can help tumors grow. Blends also make it harder to verify content: a COA should show the identity and amount of each peptide, not just total weight. Both peptides are banned in sport by WADA.

No. Neither BPC-157 nor TB-500 is FDA-approved, and there is no approved blend.

In April 2026, the FDA removed BPC-157, TB-500, KPV and several other peptides from its “Category 2” list of compounding ingredients with significant safety concerns. In July 2026, the FDA’s Pharmacy Compounding Advisory Committee voted narrowly (8–6) to recommend adding BPC-157, TB-500 and KPV to the 503A Bulks List. That vote is advisory only. As of October 2026, the FDA has not added them to the list, so they still cannot be legally compounded, and none is an approved drug.

Wolverine vs GLOW. GLOW adds GHK-Cu, a copper peptide studied for skin and collagen. Wolverine vs KLOW. KLOW adds both GHK-Cu and KPV. More ingredients mean more variables and more to verify on the COA.

Products sold as Wolverine Blend by research suppliers are laboratory chemicals, not medicines. They are not made under drug manufacturing rules, so quality varies a lot between vendors. If you are evaluating a Wolverine Blend supplier for lab research, these are the checks that matter:

• Batch-specific COA: the certificate should match the lot number on your vial, not a generic sample.
• Independent lab: testing should come from a named third-party lab, ideally with a way to verify the report online.
• Identity, not just purity: HPLC purity alone does not confirm the right molecule; look for mass spectrometry (MS) identity confirmation.
• Endotoxin and sterility results: these matter for any injectable research material.
• Correct fill amount: the measured content should be close to the labeled milligrams.

Our Trusted Sources page lists vendors we track, with current community codes. Our guide to reading a certificate of analysis explains each line of a COA.

• Wolverine is a supplier name for a BPC-157 + TB-500 blend.
• Each peptide has animal data for tissue repair; human data are very limited.
• The combination itself has never been studied.
• An FDA advisory committee narrowly backed both peptides for compounding in July 2026, but the FDA has not acted.
• Neither is FDA-approved, and both are banned by WADA.

What is the Wolverine peptide blend?

It is a research supplier blend of BPC-157 and TB-500, two peptides studied mainly in animals for tissue repair.

Does the Wolverine blend work?

Each peptide has animal data for healing, but the combination has never been studied, and human data are very limited.

Is the Wolverine blend FDA-approved?

No. Neither BPC-157 nor TB-500 is FDA-approved. An advisory committee recommended adding them to the compounding list in July 2026, but the FDA has not acted.

What is the difference between Wolverine and GLOW?

GLOW adds GHK-Cu, a copper peptide studied for skin and collagen, to BPC-157 and TB-500.

Are BPC-157 and TB-500 banned in sports?

Yes. Both are on the WADA Prohibited List.

• Chang et al. (2011), Journal of Applied Physiology – The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
• Goldstein et al. (2012), Expert Opinion on Biological Therapy – Thymosin β4: a multi-functional regenerative peptide
• FDA – Pharmacy Compounding Advisory Committee meeting, July 23–24, 2026
• WADA – 2026 Prohibited List (S0 non-approved substances; S2 peptide hormones and growth factors)